Enterome SA announced that it has received €32 million in funding from Seventure Partners, Lundbeckfond Invest A/S, Omnes Capital S.A.S., Nestlé Health Science S.A., Principia Società Di Gestione Del Risparmio S.P.A., Bristol-Myers Squibb Company

Enterome SA announced that it has received €32 million in its series D round of funding led by new investor Principia Società Di Gestione Del Risparmio (SGR) S.P.A. on January 4, 2018. The company issued equity in the transaction. The transaction included participation from existing investor Health for Life Capital, a fund managed by Seventure Partners, Lundbeckfond Ventures, Omnes Capital S.A.S., Nestlé Health Science S.A., new investor Bristol-Myers Squibb Company.